/

Precede Biosciences

Develops a blood-based epigenomics platform for precision medicine.

BiotechnologyMedical Diagnostics precede.bio ↗

Company facts

Founded: 2021
Employees: 51
Headquarters: United States
Type: Private
Funding: Series B · $83.5M · 2026